Skip to main content

Advertisement

Table 2 Psychiatric medication

From: Combination therapy as a potential risk factor for the development of type 2 diabetes in patients with schizophrenia: the GOMAP study

  SCZ without T2D SCZ with T2D
Monotherapy
 FGA 246 (17.7%) 127 (9.14%)
 SGA 126 (9.06%) 89 (6.40%)
Combination Therapy
 2-Drug Combination (Antipsychotic + 1 more psychiatric medication) 361 (25.97%) 209 (15.04%)
 ≥3-Drug Combination (Antipsychotic + 2 or more psychiatric medications) 121 (8.71%) 111 (7.99%)
  1. FGA first generation antipsychotics, SGA second generation antipsychotics